Orthostatic hypertension due to vascular adrenergic hypersensitivity

Hypertension

Volumn 28, Issue 1, 1996, Pages 42-46

  Benowitz, Neal L ^a   Zevin, Shoshana ^a   Carlsen, Sandra ^a   Wright, Janet ^a   Schambelan, Morris ^a   Cheitlin, Melvin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hypertension, orthostatic; posture; vascular resistance

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; ATROPINE; CAPTOPRIL; CLONIDINE; GLYCERYL TRINITRATE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISOPRENALINE; METOPROLOL; NORADRENALIN; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; SARALASIN;

ADRENERGIC SYSTEM; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; BODY POSTURE; CASE REPORT; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEADACHE; HEART CATHETERIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORTHOSTATIC HYPERTENSION; PHARMACOLOGICAL BLOCKING; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; VERTIGO;

EID: 0029946573     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.1.42     Document Type: Article

References (25)

1. Currens JH. A comparison of the blood pressure in the lying and standing positions: a study in five hundred men and five hundred women. Am Heart J. 1948;35:646-654.
2. Frohlich ED, Tarazi RC, Ulrych M, Dustan HP, Page IH. Tilt test for investigating a neural component in hypertension: its correlation with clinical characteristics. Circulation. 1967;36:387-393.
3. Laurent S, Juillerat L, London GM, Nussberger J, Brunner H, Safar ME. Increased response of brachial artery diameter to norepinephrine in hypertensive patients. Am J Physiol. 1988;255:H36-H43.
4. Ziegler MG, Mills P, Dimsdale JE. Hypertensives' pressor response to norepinephrine: analysis by infusion rate and plasma levels. Am J Hypertens. 1991;4:586-591.
5. Kaplan NM. Two faces of sympathetic nervous activity: hypotension and hypertension. Am J Med Sci. 1992;303:271-279.
6. Hollister AS. Orthostatic hypotension: causes, evaluation and management. West J Med. 1992;157:652-657.
7. Streeten DHP, Auchincloss JH, Anderson GH, Richardson RL, Thomas FD, Miller JW. Orthostatic hypertension: pathogenic studies. Hypertension. 1985;7:196-203.
8. Tsukamoto Y, Komuro Y, Akutsu F, Fuji K, Marumo F, Kusano S, Kikawada R. Orthostatic hypertension due to coexistence of renal fibromuscular dysplasia and nephroptosis. Jpn Circ J. 1988;52:1408-1414.
9. Takada Y, Shimizu H, Kazatani Y, Azechi H, Hiwada K, Kokubu T. Orthostatic hypertension with nephroptosis and aortic disease. Arch Intern Med. 1984;144:152-154.
10. Sapru RP, Sleight P, Anand IS, Sambhi MP, Lopez R, Chhuttani PN. Orthostatic hypertension. Am J Med. 1979;66:177-182.
11. Araki K, Ueda Y, Kono I, Ookawara T, Kashima K. A case of neurogenic Orthostatic hypertension. Jpn J Med. 1991;30:446-451.
12. Meier A, Weidmann P, Grimm M, Keusch G, Glück Z, Minder I, Ziegler WH. Pressor factors and cardiovascular pressor responsiveness in borderline hypertension. Hypertension. 1981;3:367-372.
13. Ensinger H, Stein B, Jager O, Grunert A, Ahnefeld FW. Relationship between infusion rates, plasma concentrations, and cardiovascular and metabolic effects during the infusion of norepinephrine in healthy volunteers. Crit Care Med. 1992;20:1250-1256.
14. Wilcox CS, Aminoff MJ. Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome. J Clin Pharmacol. 1976;3:207-214.
15. Kaplan NM, Silah JG. The effect of angiotensin II on the blood pressure in humans with hypertensive disease. J Clin Invest. 1964;43:659-669.
16. Bianchetti MG, Bereta-Piccoli C, Weidmann P, Ferrier C. Blood pressure control in normotensive members of hypertensive families. Kidney Int. 1986;29:882-888.
17. Cleaveland CR, Rangno RE, Shand DG. A standardized isoproterenol sensitivity test. Arch Intern Med. 1972;130:47-52.
18. Davies AO, Mares A, Pool JL, Taylor AA. Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. Am J Med. 1987; 82:193-200.
19. Palmero HA, Caero TF, Iosa DJ, Bas J. Baroreceptor reflex sensitivity index derived from phase 4 of the Valsalva maneuver. Hypertension. 1981;3(suppl II):II-134-II-137.
20. Goldstein DS. Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. Circulation. 1983;68:234-240.
21. Polinsky RJ, Kopin IJ, Ebert MH, Weise V. Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology. 1981;31:1-7.
22. Widgren BR, Herlitz H, Aurell M, Berglund G, Wikstrand J, Andersson OK. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am J Hypertens. 1992;5:167-174.
23. Gaffney AF, Bastian BC, Lane LB, Taylor WF, Horton J, Schutte JE, Graham RM, Pettinger W, Blomqvist CG. Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol. 1983;52:316-320.
24. Taylor AA. Autonomic control of cardiovascular function: clinical evaluation in health and disease. J Clin Pharmacol. 1994;34:363-374.
25. Sleight P. Importance of cardiovascular reflexes in disease. Am J Med. 1988;84(suppl 3A):92-96.